Log in
Enquire now
‌

CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT00991679
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT009916790
Health Conditions in Trial
Dry eye syndrome
Dry eye syndrome
0
Trial Recruitment Size
480
Clinical Trial Start Date
2008
0
Primary Completion Date
2008
0
Study Completion Date
2008
0
Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Case-Control0
Observational Study Perspective
Prospective0
Official Name
Expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the Tear Film and Ocular Surface of Patients With Dry Eye Syndrome0
Last Updated
October 8, 2009
0
Study summary

The aim of this study is to investigate the expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Thirty-three patients with dry eye (16 Sjögren's syndrome and 17 non-Sjögren's syndrome patients) and 15 control subjects were recruited. The concentrations of CXCL9, CXCL10, and CXCL11 in tears were measured using enzyme-linked immunosorbent assay. The correlation between chemokine levels and tear film and ocular surface parameters was analyzed. Expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the conjunctiva was evaluated using immunohistochemistry. Flow cytometry was performed to count CXCR3+ cells and CXCR3+CD4+ cells in the conjunctiva.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.